The Perrigo Company today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex gum USP, 2 mg (coated fruit) and 4 mg (coated fruit).
The product will be marketed under store brand labels and is comparable to GlaxoSmithKline's Nicorette(R) Fruit Chill(TM) coated gum, which is an aid to smoking cessation. "This first store brand approval of coated fruit nicotine gum extends our leading store brand position.
The expanded range of smoking cessation products also includes coated mint-flavored gum, uncoated gum and lozenges," said Joseph C. Papa, Perrigo's President and Chief Executive Officer. Nicorette(R) Fruit Chill(TM) gum is selling at an annual rate estimated at over $70 million at all retail outlets. First shipments are expected within the first quarter of fiscal 2008.
The Perrigo Company is a leading global healthcare supplier and the world's largest manufacturer of over-the-counter (OTC) pharmaceutical and nutritional products for the store brand market. Store brand products are sold by food, drug, mass merchandise, dollar store and club store retailers under their own labels. The Company also develops, manufactures and markets prescription generic drugs, active pharmaceutical ingredients and consumer products, and operates manufacturing facilities in the United States, Israel, United Kingdom, Mexico, Germany and China.
Note: Certain statements in this press release are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially diPage: 1 2 Related medicine news :1
. Fifth US Patient Receives Artificial Heart
. Northfield Labs Receives FDA Comments 3
. British MPs Say Prostate Cancer Receives Low Priority in the NHS4
. Abbott Receives CE Mark Certification5
. Zactima Receives Fast Track Designation By The FDA6
. East London Receives World Class New Private Hospital Facility7
. Brinda Karat Receives Legal Notice over Ramdev Issue8
. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba9
. Medtronic’s Insulin Pump Receives Regulatory Approva10
. Aurobindo Receives Approval from USFDA for anti-AIDS drug11
. Sunscreen Blocking UVA Radiation Receives Federal Approval